Fig. 4 | Scientific Reports

Fig. 4

From: Effect of PCSK9 inhibitors on the quality of life in patients with acute coronary syndromes — exploratory analysis of the EMSIACS trial

Fig. 4

Differences in PROMIS scores for PCSK9i and Statins. a and d Change of PROMIS scores at baseline, week 12, and week 48 of the two groups. (b-c) Comparison of GPH instrument items between the two groups at week 12, and week 48. (e-f) Comparison of GMH instrument items between the two groups at week 12, and week 48. PH, physical health; PF, physical function; FA, fatigue; PI, pain intensity; QoL, overall quality of life; MH, mental health; SA, satisfaction with social activities; EP, emotional problems.

Back to article page